Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Mortellaro

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Nature Communications|June 29, 2017
E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDPPradeep Bist, Wan Shoo Cheong, Aylwin Ng, et al.
Blood Advances|August 23, 2021
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiencyMatteo Zoccolillo, Immacolata Brigida, Federica Barzaghi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene TherapyRaisa Jofra Hernández, Andrea Calabria, Francesca Sanvito, et al.
Nature Communications|August 11, 2015
Genome-wide analysis of the genetic regulation of gene expression in human neutrophilsAnand Kumar Andiappan, Rossella Melchiotti, Tuang Yeow Poh, et al.
Molecular Therapy. Methods & Clinical Development|December 1, 2025
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2Chiara Rigamonti, Dimitri Bulté, Federica Barzaghi, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2024
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severitiesDimitri Bulté, Federica Barzaghi, Cristina Mesa-Nuñez, et al.
International Journal of Molecular Sciences|July 2, 2021
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal AdenocarcinomaHweixian Leong Penny, Je Lin Sieow, Sin Yee Gun, et al.
Frontiers in Immunology|October 17, 2022
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiencyFederica Barzaghi, Maria Pia Cicalese, Matteo Zoccolillo, et al.
Disease Models & Mechanisms|March 5, 2026
Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone diseaseMargherita Berti, Selene Ceriotti, Ludovica Santi, et al.
Nature|November 2, 2023
IL-1β<sup>+</sup> macrophages fuel pathogenic inflammation in pancreatic cancerNicoletta Caronni, Federica La Terza, Francesco M Vittoria, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Nature Communications|June 29, 2017
E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDPPradeep Bist, Wan Shoo Cheong, Aylwin Ng, et al.
Blood Advances|August 23, 2021
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiencyMatteo Zoccolillo, Immacolata Brigida, Federica Barzaghi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene TherapyRaisa Jofra Hernández, Andrea Calabria, Francesca Sanvito, et al.
Nature Communications|August 11, 2015
Genome-wide analysis of the genetic regulation of gene expression in human neutrophilsAnand Kumar Andiappan, Rossella Melchiotti, Tuang Yeow Poh, et al.
Molecular Therapy. Methods & Clinical Development|December 1, 2025
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2Chiara Rigamonti, Dimitri Bulté, Federica Barzaghi, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2024
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severitiesDimitri Bulté, Federica Barzaghi, Cristina Mesa-Nuñez, et al.
International Journal of Molecular Sciences|July 2, 2021
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal AdenocarcinomaHweixian Leong Penny, Je Lin Sieow, Sin Yee Gun, et al.
Frontiers in Immunology|October 17, 2022
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiencyFederica Barzaghi, Maria Pia Cicalese, Matteo Zoccolillo, et al.
Disease Models & Mechanisms|March 5, 2026
Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone diseaseMargherita Berti, Selene Ceriotti, Ludovica Santi, et al.
Nature|November 2, 2023
IL-1β<sup>+</sup> macrophages fuel pathogenic inflammation in pancreatic cancerNicoletta Caronni, Federica La Terza, Francesco M Vittoria, et al.
Pageof 6